会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
    • S-甲基 - 二氢 - 齐拉昔酮用于治疗精神病和眼部疾病
    • US20060287336A1
    • 2006-12-21
    • US09873973
    • 2001-06-04
    • Chandra PrakashTerese Smolarek
    • Chandra PrakashTerese Smolarek
    • A61K31/496
    • A61K31/22A61K31/496
    • This invention relates to pharmaceutical compositions containing S-methyl-dihydro-ziprasidone and to the use of such compound and its pharmaceutically acceptable salts for the treatment of psychiatric and ocular disorders. More specifically, it relates to the use of such compound and its pharmaceutically acceptable salts for the treatment of a disorder or condition selected from: schizophrenia, anxiety disorders such as generalized anxiety disorder, panic disorder, posttraumatic stress disorder and phobias (e.g., social phobia, agoraphobia etc.); psychotic episodes of anxiety: anxiety, agitation, excessive aggression, tension, or social or emotional withdrawal associated with psychosis; psychotic mood disorders such as severe major depressive disorder; mood disorders associated with psychotic disorders such as acute mania and depression associated with bipolar disorder, and mood disorders associated with schizophrenia; behavioral disturbances associated with mental retardation, autistic disorder, and conduct disorder; dementias such as dementias associated with Alzheimer's disease; drug-induced and neurodegeneration based dyskinesias; obsessive compulsive disorder; Tourette's syndrome; glaucoma; and ischemic retinopathy.
    • 本发明涉及含有S-甲基 - 二氢 - 齐拉西酮的药物组合物以及这种化合物及其可药用盐在治疗精神病和眼部疾病中的用途。 更具体地说,它涉及这种化合物及其药学上可接受的盐在治疗选自以下的病症或病症中的用途:精神分裂症,焦虑症例如广泛性焦虑症,惊恐障碍,创伤后应激障碍和恐惧症(例如社交恐惧症 ,广场恐怖等); 焦虑的精神病发作:与精神病有关的焦虑,激动,过度侵略,紧张或社会或情绪退缩; 精神病心理障碍如重度抑郁障碍; 与精神病性疾病相关的情绪障碍,例如与双相障碍相关的急性躁狂症和抑郁症,以及与精神分裂症相关的情绪障碍; 与精神发育迟滞,自闭症和行为障碍相关的行为障碍; 痴呆症如与阿尔茨海默病相关的痴呆; 药物诱导和神经退行性运动障碍; 强迫症 图雷特综合征 青光眼; 和缺血性视网膜病变。